NCT01033318View on ClinicalTrials.gov

A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 11, 2007

Primary Completion Date

June 19, 2008

Study Completion Date

June 19, 2008

Conditions
Hypertension
Interventions
DRUG

MK1809

single oral doses of MK1809

DRUG

Comparator: Losartan

single oral doses of 100 mg Losartan

DRUG

Comparator: Placebo

Placebo to MK1809

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01033318 - A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED) | Biotech Hunter | Biotech Hunter